Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Delirium Prevention in Otolaryngeal Cancer Surgery
NCT03040024Phase 4Terminated
- Sponsor
- Emory University
- Start
- Mar 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in delirium, sponsored by Emory University. Started Mar 2017; status: terminated.
02
Drugs
ketamine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT03040024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03040024.